Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies? - PubMed (original) (raw)
Review
Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?
G Missale et al. Dig Liver Dis. 2004 Nov.
Abstract
Several lines of evidence support the view that hepatitis C virus is not directly cytopathic for infected host cells and that the immune response plays a central role in the pathogenesis of liver damage. Innate and adaptive immune responses are induced in most individuals infected with hepatitis C virus but are insufficient to eliminate the virus. The mechanisms responsible for this failure are largely unknown but the kinetics of hepatitis C virus replication relative to the priming of the adaptive responses may exert a profound influence on the balance between virus and host. Immediately after hepatitis C virus infection, the virus replicates efficiently, inducing the production of type I interferons. However, the rapid increase in viral replication seems to be ignored by the adaptive immune response, and after a short interval from exposure, viral load can reach levels comparable to those of patients with established persistent infection. The CD8-mediated response shows functional defects, with impaired production of interferon-gamma, low perforin content, decreased capacity of expansion and lysis of target cells. Late appearance and functional defects of T cells in hepatitis C virus infection might be the result of the rapid increase of the viral load that could create the conditions for exhaustion of the adaptive response or reflect an insufficient function of the innate immune response. This possibility is suggested by in vitro studies showing that hepatitis C virus gene products can interfere with the anti-viral activity of type I interferons and natural killer cells as well as with the maturation of dendritic cells. While T-cell defects are reversed in a minority of infected individuals who succeed in controlling the infection, the T-cell impairment becomes progressively more profound as infection progresses to chronicity. In this situation, therapeutic restoration of adaptive responses may represent a rational strategy to obtain resolution of infection and to complement available therapies. The peculiar kinetics of hepatitis C virus replication and T-cell induction soon after infection may have important implications also for the design of protective vaccines since memory responses may not be able to precede the early peak of viral replication. Therefore, vaccines against hepatitis C virus may be unable to prevent infection but may rather be effective in facilitating a self-limited evolution of infection.
Similar articles
- [Immunopathology of chronic liver diseases].
Meyer zum Büschenfelde KH. Meyer zum Büschenfelde KH. Verh Dtsch Ges Pathol. 1995;79:186-97. Verh Dtsch Ges Pathol. 1995. PMID: 8600684 Review. German. - Hepatitis C virus and the immune system: a concise review.
Gremion C, Cerny A. Gremion C, et al. Rev Med Virol. 2005 Jul-Aug;15(4):235-68. doi: 10.1002/rmv.466. Rev Med Virol. 2005. PMID: 15782389 Review. - A target on the move: innate and adaptive immune escape strategies of hepatitis C virus.
Thimme R, Lohmann V, Weber F. Thimme R, et al. Antiviral Res. 2006 Mar;69(3):129-41. doi: 10.1016/j.antiviral.2005.12.001. Epub 2006 Jan 4. Antiviral Res. 2006. PMID: 16413618 Review. - Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
Bode JG, Brenndörfer ED, Häussinger D. Bode JG, et al. Biol Chem. 2008 Oct;389(10):1283-98. doi: 10.1515/BC.2008.147. Biol Chem. 2008. PMID: 18713016 Review. - Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA, Llorente S, Castillo I, Rodríguez-Iñigo E, López-Alcorocho JM, Pardo M, Carreño V. Quiroga JA, et al. J Med Virol. 2006 Sep;78(9):1190-7. doi: 10.1002/jmv.20680. J Med Virol. 2006. PMID: 16847959
Cited by
- Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection.
Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K. Kolumam GA, et al. J Exp Med. 2005 Sep 5;202(5):637-50. doi: 10.1084/jem.20050821. Epub 2005 Aug 29. J Exp Med. 2005. PMID: 16129706 Free PMC article. - The IL6-174G/C Polymorphism Associated with High Levels of IL-6 Contributes to HCV Infection, but Is Not Related to HBV Infection, in the Amazon Region of Brazil.
Queiroz MAF, Santiago AM, Moura TCF, Amoras EDSG, Conde SRSDS, Cayres-Vallinoto IMV, Ishak R, Vallinoto ACR. Queiroz MAF, et al. Viruses. 2022 Feb 28;14(3):507. doi: 10.3390/v14030507. Viruses. 2022. PMID: 35336914 Free PMC article. - Immune response of cytotoxic T lymphocytes and possibility of vaccine development for hepatitis C virus infection.
Hiroishi K, Eguchi J, Ishii S, Hiraide A, Sakaki M, Doi H, Omori R, Imawari M. Hiroishi K, et al. J Biomed Biotechnol. 2010;2010:263810. doi: 10.1155/2010/263810. Epub 2010 May 20. J Biomed Biotechnol. 2010. PMID: 20508848 Free PMC article. - Hepatitis C Virus Infection: Host⁻Virus Interaction and Mechanisms of Viral Persistence.
Chigbu DI, Loonawat R, Sehgal M, Patel D, Jain P. Chigbu DI, et al. Cells. 2019 Apr 25;8(4):376. doi: 10.3390/cells8040376. Cells. 2019. PMID: 31027278 Free PMC article. Review. - A case of disseminated cryptococcus in an immunocompetent individual necessitating ventriculoperitoneal shunt.
Myers D, McVaney B, Higginbotham Z. Myers D, et al. Med Mycol Case Rep. 2021 Mar 17;32:53-55. doi: 10.1016/j.mmcr.2021.03.001. eCollection 2021 Jun. Med Mycol Case Rep. 2021. PMID: 33898212 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials